Recently, several studies have demonstrated that metformin inhibits HIF-1α expression in patients with breast cancer [16] or hepatocellular carcinoma Bel-7402/5-fluorouracil (Bel-Fu) cells [17]. Here, HIF1A is linked to breast cancer.